Sarr - Parnassia Groep Antes
Rotterdam, Netherlands
Location status: Recruiting
NCT Number: NCT06726187
Rationale: Self-report measures are frequently used for research and clinical assessments of adults with autism spectrum disorder (ASD). However, there has been little research examining agreement between self-report and informant-report in this population. Reliable self-report measures are essential for conducting research with and providing high quality clinical services for adults with autism spectrum disorder.
Objective: This study aims to examine the usefulness of self-report of DSM-5-TR PD traits in adults with ASD compared to informant-reports by administering the self-report screening measure of the Structured Clinical Interview for DSM-5 Screening Personality Questionnaire (SCID-5-SPQ).
Interested in participating?
Request Info18 year and older
All sexes
Observational
Rotterdam, Netherlands
Location status: Recruiting
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Inclusion criteria for ASD participants: (1) primary diagnosis of ASD according to the DSM-5-TR, (2) age 18+ years, (3) no intellectual disability, and (4) at least having completed a primary and secondary education.
Inclusion criteria
for informants:
Participants were asked to identify individuals who knew them well and were capable of providing accurate descriptions of their personality traits, preferably informants that cohabited with the participants. When cohabitants were unavailable, participants were asked to identify "the person who knows you best." Additionally, eligibility of informants for inclusion required that, historically, the informant and the participant talked at least monthly and interacted face-to-face at least yearly.
Exclusion criteria
Exclusion criteria for ASD participants: (1) no ASD diagnosis, (2) current substance abuse, (3) psychotic disorders, (4) schizophrenia, (5) eating disorder, (6), mental retardation (IQ<80), (7) suicidal ideations and (8) age <18 years.
Exclusion criteria
for informants: (1) age <18 years, (2) intellectual disability, and (3) not being able to state and/or recognize psychological and problematic functioning of their participating relative with ASD.
Screening questionnaire
Time frame: 1 day
The main study parameters are the item scores on the Structured Clinical Interview for DSM-5 Personality Disorders (SCID-5-PD). The participant can score with Yes and No on the questions. The scoring parameters are 0 (No) and 1 (Yes). This is for all items. A higher score means that the participant scores on that personality item.
Parnassia Groep
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06081348
22Q11 Deletion, 22q11 Deletion Syndrome
Calgary, Alberta, Canada
View Trial DetailsNCT03866668
Autism, Autism Spectrum Disorder
Stanford, California, United States
View Trial DetailsNCT06362733
Autism, Autism Spectrum Disorder
Stanford, California, United States
View Trial DetailsNCT04899544
ASD, Autism
Stanford, California, United States
View Trial Details